Skip to main content
Signal8

TREACE MEDICAL CONCEPTS, INC. (TMCI)

Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty System, enables surgeons to correct all three dimensions of the bunion deformity, stabilize the first TMT joint, and allow return to weight-bearing in a walking boot; minimally invasive products for four bunion classes; Nanoplasty 3D Minimally Invasive Bunion Correction System delivers a reproducible 3D correction of the bunion deformity through a cosmetically appealing; and Percuplasty Percutaneous 3D Bunion Correction System that provides 3D correction of the bunion deformity through percutaneous incisions. It also provides Adductoplasty System, a system designed for the correction of metatarsus adductus deformities and osteoarthritis of the midfoot; SpeedMTP Rapid Compression Implant; SpeedPlate Implant Fixation Platform to address the fusion of larger bones of the midfoot and rearfoot; SpeedPlate Micro-Quad implant, an implant designed for stability and fit in small incision surgical approaches; and SpeedAkin Anatomic Compression Implant. In addition, the company offers The IntelliGuide patient specific instrumentation provides patient-specific, 3D-printed cut guides, and a pre-operative plan for a complete picture of the deformity and correction. Further, it provides FastGrafter Autografter Harvesting System; SpeedRelease Guided Release Instrument; TriTome Triple-Edge Release Instrument; RazorTome 7mm Precision Osteotome; LapiTome Hooked Bone Removal Osteotome; GreatRelease Rapid MTP Release Instrument; CornerChisel Release Tool; NanoRasp MIS Bone Contouring Tool; FeatherRasp Rapid Bone Contouring Instrument; and Akinator Single-cut Akin Wedge Osteotomy tool. Additionally, the company offers biologics and wedges, such as Treace Allograft Wedges; and CortiFuse Flowable Cortical Fibers. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra, Florida.

Sector: Surgical & Medical Instruments & Apparatus

Industry: Medical - Devices

Treace Medical Concepts, Inc. logo

Treace Medical Concepts, Inc.

NASDAQ:TMCIHealthcare
-12.45%$4.43
AH$4.49+1.35%vs close
Mkt Cap$288.69M
Float51.6M
O/S65.17M
Vol
$ Vol
RVOL
Inst Own48.9%
Earnings
Dilution
Pipeline4 lead-sponsored trials·3 active0 completed

Trials need funding. See this company's dilution risk and cash position.

Clinical Trials
Status
  • Not applicable
    Active, not recruiting

    Early Weight-Bearing After the Lapiplasty Procedure

    Lapiplasty

    Hallux Valgus, Bunion

    Enrollment
    183
    Start
    Nov 2018
    Primary Completion
    May 2023
    Completion
    May 2026est.
    NCT03740282
  • Not applicable
    Terminated

    Early Weight-Bearing After the Lapiplasty Mini-Incision Procedure (Mini3D)

    Treatment of Hallux Valgus

    Hallux Valgus, Bunion

    Enrollment
    123
    Start
    Sep 2021
    Primary Completion
    May 2024
    Completion
    May 2024
    NCT05082012
  • Not applicable
    Recruiting

    Outcomes Following Combined Adductoplasty™ and Lapiplasty® (MTA3D)

    Treatment of metatarsus adductus and hallux valgus with the Adductoplasty™ Procedure in combination with the Lapiplasty® Procedure

    Metatarsus Adductus, Hallux Valgus

    Enrollment
    80
    Start
    Sep 2022
    Primary Completion
    Dec 2026est.
    Completion
    Dec 2030est.
    NCT05587569
  • Observational
    Active, not recruiting

    The SpeedPlate™ Rapid Compression Implant Study (The SPRINT™ Study)

    SpeedPlate™ Rapid Compression Implants

    Joint Arthrodesis, Joint Fixation

    Enrollment
    92
    Start
    Sep 2024
    Primary Completion
    Mar 2026est.
    Completion
    Dec 2026est.
    NCT06548581